Atlas Trials

Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis

Clinical trial NCT01321567 · COMPLETED

Trial details

NCT number
NCT01321567
Sponsor
Eisai Co., Ltd.
Status
COMPLETED
Study type
OBSERVATIONAL
Refractory Reflux Esophagitis
Start date
2011-01-01
Primary completion
2013-03-01
Enrollment
2157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.